Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ImmunityBio (IBRX) Return on Equity: 2015-2025

Historic Return on Equity for ImmunityBio (IBRX) over the last 10 years, with Sep 2025 value amounting to 0.64%.

  • ImmunityBio's Return on Equity fell 18.00% to 0.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.64%, marking a year-over-year decrease of 18.00%. This contributed to the annual value of 0.77% for FY2024, which is 36.00% down from last year.
  • Latest data reveals that ImmunityBio reported Return on Equity of 0.64% as of Q3 2025, which was up 0.79% from 0.63% recorded in Q2 2025.
  • In the past 5 years, ImmunityBio's Return on Equity registered a high of 1.88% during Q3 2021, and its lowest value of 0.63% during Q2 2025.
  • Its 3-year average for Return on Equity is 0.82%, with a median of 0.82% in 2024.
  • In the last 5 years, ImmunityBio's Return on Equity tumbled by 8,046bps in 2021 and then rose by 22bps in 2023.
  • ImmunityBio's Return on Equity (Quarterly) stood at 1.61% in 2021, then tumbled by 66bps to 0.95% in 2022, then rose by 22bps to 1.17% in 2023, then crashed by 50bps to 0.67% in 2024, then fell by 18bps to 0.64% in 2025.
  • Its Return on Equity stands at 0.64% for Q3 2025, versus 0.63% for Q2 2025 and 0.76% for Q1 2025.